Isolated anti-ribosomal P antibodies are associated with reduced risk of renal and articular involvement in systemic lupus erythematosus patients. An observational study from one center. [PDF]
ReumatologiaElghali M +5 more
europepmc +1 more source
Feline immune-mediated skin disorders: Part 1. [PDF]
J Feline Med SurgBanovic F, Gomes P, Trainor K.
europepmc +1 more source
The Steroid Veil: Complications in Identifying Lupus. [PDF]
CureusHingtgen GM +2 more
europepmc +1 more source
Successful treatment of recalcitrant cutaneous lupus erythematosus with anifrolumab in patients without systemic lupus erythematosus. [PDF]
JAAD Case RepAbdelmalik B +3 more
europepmc +1 more source
Topical miRNA Delivery via Elastic Liposomal Formulation: A Promising Genetic Therapy for Cutaneous Lupus Erythematosus (CLE). [PDF]
Int J Mol SciJoseph-Mullol B +7 more
europepmc +1 more source
Cutaneous lupus erythematosus following immunoglobulin therapy in dermatomyositis. [PDF]
J DermatolAlhassan E +3 more
europepmc +1 more source
Superficial Skin Ulcers as an Initial Manifestation of Systemic Lupus Erythematosus. [PDF]
CureusSantacruz JC +5 more
europepmc +1 more source
Characteristics and clinical outcomes of patients with systemic lupus erythematosus initiating anifrolumab in a real-world setting in Spain (AZAHAR study): an observational study protocol. [PDF]
Lupus Sci MedGalindo-Izquierdo M +4 more
europepmc +1 more source
Primary cutaneous Mycobacteria avium complex infection in a systemic lupus erythematosus patient: A case report and review. [PDF]
Medicine (Baltimore)Yao QH +5 more
europepmc +1 more source